Biotechnology
Avance Clinical Earns Frost & Sullivan's 2023 Best Practices Customer Value Leadership Award for Delivering High-quality Clinical Trials Based on Globally Accepted Data
Avance Clinical is an Australian and North American market-leading Contract Research Organization (CRO) that provides international biotechs with customized solutions.For the fourth consecutive year, Avance Clinical has been awarded Best Practices Customer Value Leadership awarded, by Frost & Sul...
2023-08-07 08:00
1277
AI+ Media Development Platform AlfaOPA™ Officially Launched
HONG KONG, Aug. 4, 2023 /PRNewswire/ -- Today, the Future Technology: AI Empowering Bioprocessing Development summit hosted by Great Bay Bio (hereinafter referred to as "GBB") was successfully held at the Suzhou International Expo Center, where industry players gathered to celebrate the feast of...
2023-08-04 11:13
3494
Shenzhen to Foster Quantitative Biology Stronghold
SHENZHEN, China, Aug. 3, 2023 /PRNewswire/ -- An international conference on quantitative biology was held recently inSouthern China's Shenzhen, drawing over 300 participants from more than 20 universities worldwide to discuss illuminating opportunities and shaping the future of quantitative and ...
2023-08-03 21:34
2445
Shenzhen to Foster Quantitative Biology Stronghold
SHENZHEN, China, Aug. 3, 2023 /PRNewswire/ -- An international conference on quantitative biology was held recently inSouthern China's Shenzhen, drawing over 300 participants from more than 20 universities worldwide to discuss illuminating opportunities and shaping the future of quantitative and ...
2023-08-03 19:00
1621
MANA Develops Novel "Drycell" Microdroplets to Make Handling Single Cell Easier
TSUKUBA, Japan, Aug. 3, 2023 /PRNewswire/ -- Scientists at the Research Center for Materials Nanoarchitectonics (MANA) have developed micrometer-sized "liquid marbles" that can encapsulate single to several living cells, thereby aiding single-cell studies. To analyze individual cells, the desire...
2023-08-03 16:00
1093
Cicada Innovations to launch new incubator at Westmead Health & Innovation District, backed by Investment NSW
SYDNEY, Aug. 3, 2023 /PRNewswire/ -- Australia's flagship deep tech incubator
Cicada Innovations
2023-08-03 12:15
2227
ESMO 2023 | Ascentage Pharma to Present Results from Two Clinical Studies, including One Oral Presentation, at 2023 ESMO Congress
SUZHOU, China, and ROCKVILLE, Md., Aug. 2, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it is going to release results from two clinic...
2023-08-03 11:43
1329
SK Biopharmaceuticals Assembles 'Board of Prominent Experts' to Boost Growth, Innovation
Renowned oncologist Yung-Jue Bang, M.D., Ph.D., chairs the distinguished 5-member Scientific Advisory Board to further advance SK Biopharmaceuticals as a global big biotech SEOUL, South Korea, Aug. 2, 2023 /PRNewswire/ -- SK Biopharmaceuticals, a global biotech company, announced the formation o...
2023-08-03 07:30
1404
Arbele announces early safety data for novel CDH17xCD3 bispecific T-cell engager at American Society of Clinical Oncology Breakthrough Meeting
SYDNEY, Aug. 2, 2023 /PRNewswire/ -- Arbele, a clinical-stage biotechnology company developing novel immunotherapies targeted for advanced gastrointestinal cancers, presented early safety data from its first-in-class CDH17xCD3 bispecific T-cell engager antibody, ARB202, at the ASCO Breakthrough c...
2023-08-03 07:00
1297
U.S. FDA Grants Orphan Drug Designation to ABM-1310 for the Treatment of Patients with Glioblastoma Harboring BRAF V600 Mutation
SAN DIEGO and SHANGHAI, Aug. 2, 2023 /PRNewswire/ -- ABM Therapeutics (ABM) announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to ABM-1310, a novel small molecule BRAF inhibitor developed by the company, for the treatment of patients with g...
2023-08-03 00:00
1258
Atantares has Completed Two Rounds of RMB100 Million Financing, and the Pre-A Round is led by Asia Green Fund
BEIJING, Aug. 2, 2023 /PRNewswire/ -- Recently, Atantares announced the completion of Pre-A and Pre-A+ financing all aroundRMB100 million. The Pre-A round is led by Asia Green Fund, followed by Fosun Health Capital and existing investors Frees Fund, Qiming Venture Partners, Next Capital, and NeuX...
2023-08-02 14:56
1768
Selected for oral presentation! Kelun-Biotech to announce latest clinical study results of SKB264 (MK-2870, TROP2-ADC) for treatment of HR+/HER2- breast cancer at ESMO Congress 2023
CHENGDU, China, Aug. 1, 2023 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", HKEX: 6990.HK) announced that it will present the data from a Phase I/II clinical trial of the innovative TROP2-ADC (SKB264, MK-2870) jointly developed by Kelun-Biotech and MSD (the t...
2023-08-01 21:07
2506
Lunit Presents Groundbreaking Study on Predicting Treatment Response by HER2 Analysis in Colorectal Cancer
- Collaborative study with NCCHE shows that AI analysis of HER2 expression and the tumor microenvironment is linked to treatment response of Pertuzumab+Trastuzumab in colorectal cancer SEOUL, South Korea, Aug. 1, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered soluti...
2023-08-01 21:00
1683
Peijia Medical Announces First Chinese Patient Implanted with TaurusTrio™ Transcatheter Aortic Valve Replacement System
SUZHOU, China, Aug. 1, 2023 /PRNewswire/ -- Peijia Medical (HKG:9996), a leading Chinese domestic player in the high-growth transcatheter valve therapeutic and neurointerventional procedural medical device markets, announced onJuly 31, 2023 that the first Chinese patient of the multi-center ...
2023-08-01 20:00
2307
Chinese Patent Granted for A*STAR Spinoff, CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology
The Company now has exclusive rights to a US and Chinese patent.
SINGAPORE, Aug. 1, 2023 /PRNewswire/ -- CytoMed Therapeutics Limited
2023-08-01 19:00
1439
Everest Medicines Announces Completion of Patient Enrollment in Nefecon® China Open Label Extension Study
SHANGHAI, August 1, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, announced today the completion of patient enrollment for theChi...
2023-08-01 08:47
2035
Hybribio showcased cutting-edge cervical cancer HPV diagnostic solutions at ADLM 2023
ANAHEIM, Calif., July 31, 2023 /PRNewswire/ -- Hybribio (300639.SZ) exhibited live at the 75th ADLM (former AACC) Annual Scientific Meeting & Clinical Lab Expo,July 25-27, at Anaheim Convention Center, California, USA. This event attracted 958 exhibitors and over 70,000 attendees worldwide from d...
2023-08-01 01:00
1794
Seegene unveils solutions to popularize molecular diagnostics at 2023 AACC
* Introduced syndromic quantitative PCR assays and a fully automated molecular diagnostic testing system, STARlet AIOS™ * Conducted symposium sessions on the usefulness of PCR testing in diagnosing gastrointestinal diseases * Participated in a presentation event for major Korean in-vitro dia...
2023-08-01 00:00
1411
Fosun Health Capital reached a cooperation agreement with Medicilon to explore innovative drug research and development together
BOSTON, July 31, 2023 /PRNewswire/ -- On July 25, 2023, Fosun Health Capital established by Fosun Pharma (stock code:600196.SH), reached a strategic partnership with Medicilon (stock code: 688202.SH). Meanwhile StarMab Biology (Suzhou) (jointly invested by the innovation drug research fund of Fo...
2023-07-31 20:30
2206
WuXi AppTec Announced Strong Results of the Second Quarter and First Half of 2023, on Top of an Exceptionally Strong Year in 2022
* Revenue of RMB9,908 Million in the Second Quarter, Up 6.7% Year-over-Year; Excluding COVID-19 Commercial Projects, Up 39.5% * Revenue of RMB18,871 Million in the First Half, Up 6.3% Year-over-Year; Excluding COVID-19 Commercial Projects, Up 27.9% * Net Profit Attributable to Owners of the Co...
2023-07-31 18:02
4085
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
8288
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
2024-11-20 09:00
7685